• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

type 1 diabetes

GoodRx: The Average Price Per Insulin Unit Dropped 42%

by Jasmine Pennic 01/20/2025 Leave a Comment

What You Should Know:  - The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded in a decade.  - Thanks to the Inflation Reduction Act and voluntary price cuts by major insulin manufacturers, prices have seen significant declines. Products like Lantus, Novolin N, Humalog, and Humulin N are now more affordable than they have been in years. Insulin Costs
Read More

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

by Fred Pennic 03/13/2023 Leave a Comment

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

What You Should Know: - Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity value of approximately $2.9B. - The acquisition is a strategic fit for Sanofi at the intersection of the company’s growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet
Read More

The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank

by Girisha Fernando, CEO and Founder of Lyfegen 11/15/2022 Leave a Comment

The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank

Advanced medical research has brought us to the point where many serious conditions can potentially be treated and even cured - with people who have essentially faced a lifetime of being incapacitated finally able to conduct normal lives. Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The latest example–and most expensive medication to date– is bluebird bio’s recently-approved $2.8 million gene therapy to treat a rare blood
Read More

At-Home Digital Health Innovations Transforming Diabetes Care

by Mark Clements, MD, PhD, CPI, FAAP, Chief Medical Officer, Glooko, Inc. 04/04/2022 Leave a Comment

At-Home Digital Health Innovations Transforming Diabetes Care

If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding the world, consider this: The pandemic has turbocharged widespread acceptance of at-home digital health solutions. Forced to function in a world of social distancing, healthcare providers and physicians have quickly discovered how easily telehealth visits, remote patient monitoring (RPM) and digital therapeutics can improve patient care.  Many of these digital health innovations are designed to address
Read More

Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids

by David Maahs, MD, Division Chief of Pediatric Endocrinology, Stanford Children’s Health 03/22/2022 Leave a Comment

Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids

A recent study from Stanford found that pediatric patients with rapid access to continuous glucose monitoring soon after a type 1 diabetes diagnosis had healthier blood sugar values than an earlier group of patients who weren’t given the monitors near the time of diagnosis.  The research provides an example of how the healthcare industry is evolving to use technology: It provides more frequent touchpoints with caregivers, makes quality care available to a larger number of patients, and
Read More

Medtronic Launches Initiatives to Address Health Equity for People of Color Living with Diabetes

by Jasmine Pennic 04/07/2021 Leave a Comment

diabetes management qualcomm medtronic diabetes

What You Should Know: - Medtronic announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities. New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities Details of each partnership, as well as additional
Read More

Data-Driven Future: Impact of Machine Learning on Diabetes Management

by Athar Siddiqui: Global Strategy Lead, Digital Connected Solutions - Ascensia Diabetes Care 03/02/2021 Leave a Comment

Impact of Machine Learning on Diabetes

“Information technology and business are becoming inextricably interwoven. I don't think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare.  The ability to collect, analyze, and use data is becoming ubiquitous with many of healthcare’s most exciting advancements. Whether it’s Google’s DeepMind using artificial intelligence (AI) to help
Read More

NIH Funds First Nationwide Rare and Atypical Diabetes Network

by Fred Pennic 10/02/2020 Leave a Comment

NIH Funds First Nationwide Rare and Atypical Diabetes Network

What You Should Know: - NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several unusual forms of diabetes. - RADIANT plans to screen about 2,000 people with unknown or atypical forms of diabetes that do not fit the common features of type 1 and type 2 diabetes. The National Institute of Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes Network (RADIANT) that will seek
Read More

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

by Jasmine Pennic 09/02/2020 Leave a Comment

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

What You Should Know: - Medtronic announced the U.S. Food and Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump system with smartphone connectivity and an expanded age indication to patients with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for an automated insulin pump system.  - The new MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app (compatible with both iPhone and Android), and Roche Accu-Chek®
Read More

DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care

by Fred Pennic 08/10/2020 Leave a Comment

diabetes management qualcomm medtronic diabetes

What You Should Know: - DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.  - DreaMed uses AI-powered technology to seamlessly treat patients remotely with its virtual diabetes management service by
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |